Medtronic (MDT) – Research Analysts’ Recent Ratings Changes
Medtronic (NYSE: MDT) has recently received a number of price target changes and ratings updates: 1/6/2026 – Medtronic was upgraded by analysts at William Blair from a “market perform” rating to an “outperform” rating. 1/5/2026 – Medtronic had its “neutral” rating reaffirmed by analysts at Piper Sandler. 1/3/2026 – Medtronic was downgraded by analysts at [...]